Metabolic Characterization and Follow up of Adult Patients Affected by Osteogenesis Imperfecta in Long-term Treatment with Neridronic Acid
Rachele Fornari, Paolo Sgro, Emanuela Greco, Davide Francomano, Antonio Aversa, Mario Marini, Carla Lubrano, Chiara Marocco, Francesco Conti, Giovanni Spera, Luigi Di Luigi, Andrea Lenzi & Silvia Migliaccio · Journal of Advances in Medicine and Medical Research · 2011
Aims: Osteogenesis imperfecta (OI) is a rare inherited disorder causing low bone density and increased fragility. Bisphosphonates (BP) are a treatment of choice for OI. Few studies have investigated the long-term effects of BP in OI patients. Thus, aim of our study was to follow...
Open access
Research Article
10.9734/BJMMR/2011/501